[HTML][HTML] Systematically understanding the immunity leading to CRPC progression
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, F Han, H Lin, X Zhou - imagwiki.nibib.nih.gov
Acknowledgements Model Prediction and Biological Validation Data Generation and Analysis
Introduction Conclusions Systems Modeli Page 1 Acknowledgements Model Prediction and …
Introduction Conclusions Systems Modeli Page 1 Acknowledgements Model Prediction and …
Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, HK Lin, X Zhou - PLoS computational …, 2019 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
Systematically understanding the immunity leading to CRPC progression.
Z Ji, W Zhao, HK Lin, X Zhou - PLoS Computational Biology, 2019 - search.ebscohost.com
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
[引用][C] Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, HK Lin, X Zhou - PLoS Computational Biology, 2019 - ui.adsabs.harvard.edu
Systematically understanding the immunity leading to CRPC progression - NASA/ADS Now on
home page ads icon ads Enable full ADS view NASA/ADS Systematically understanding the …
home page ads icon ads Enable full ADS view NASA/ADS Systematically understanding the …
Systematically understanding the immunity leading to CRPC progression.
Z Ji, W Zhao, HK Lin, X Zhou - Plos Computational Biology, 2019 - europepmc.org
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
[PDF][PDF] Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, HK Lin, X Zhou - PLoS Comput Biol, 2019 - pdfs.semanticscholar.org
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
[HTML][HTML] Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, HK Lin, X Zhou - PLoS Computational Biology, 2019 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, HK Lin, X Zhou - PLoS Computational Biology, 2019 - hero.epa.gov
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
Systematically understanding the immunity leading to CRPC progression
Z Ji, W Zhao, HK Lin, X Zhou - PLoS Computational Biology, 2019 - go.gale.com
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …
cause of cancer-related death in American men. Androgen deprivation therapy (ADT) has …